Clinical Trials
6 trialsNCT04961619 2025-12-12
LEAD Melanoma
Novartis
Completed
NCT03944356 2025-03-12
Combi-EU
EuMelaReg gGmbH
Completed
NCT05260684 2025-03-06
OCEANMIST
Pfizer
Completed
NCT04547946 2023-05-30
Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)
Novartis
Completed
NCT05714371 2023-02-06
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
Novartis
Completed
NCT02439411 2019-12-02
DEIS
Grupo Español Multidisciplinar de Melanoma
Completed